What is RenovaCare, Inc. (RCAR) stock price today?

RenovaCare, Inc. (RCAR) is currently trading at $0.00.

What is RCAR P/E ratio?

RenovaCare, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is RCAR return on equity (ROE)?

RenovaCare, Inc.'s return on equity (ROE) is -568.90%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is RenovaCare, Inc.'s market cap?

RenovaCare, Inc. has a market capitalization of $8735.

OTC · Biotechnology

RenovaCare, Inc. (RCAR) Stock

$0.00 OTC: RCAR Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$8735
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.06
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-568.90%
ROA	-103.99%
ROCE	-230.49%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.62

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-3.0M	$-2.0M	$-4.0M	$-10.0M	$-5.0M
Net Profit	$-4.0M	$-2.0M	$-3.0M	$-10.0M	$-4.0M
EPS	$-0.05	$-0.03	$-0.04	$-0.11	$-0.05
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$3.0M	$16.0M	$12.0M	$8.0M	$4.0M
Total Liabilities	$1.0M	$0	$0	$1.0M	$1.0M
Cash	$3.0M	$15.0M	$12.0M	$7.0M	$3.0M
Borrowings	$1.0M	$0	$0	$0	$0

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-2.0M	$-2.0M	$-3.0M	$-5.0M	$-5.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$4.0M	$15.0M	$0	$0	$0
Net Cash Flow	$2.0M	$12.0M	$-3.0M	$-5.0M	$-5.0M
Free Cash Flow	$-2.0M	$-2.0M	$-3.0M	$-5.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.52
FCF Yield	-52247.02%
Quick Ratio	2.59
Interest Coverage	0.00
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASFXAmerican Scientific Resources, Incorporated	$0.00	—	—	$5251	0.00%
LOWLFLowell Farms Inc.	$0.00	—	0.00	$1815	0.00%
MDITMedite Cancer Diagnostics, Inc.	$0.00	—	0.00	$8672	0.00%
OZYMFStrategic Partners A/S	$90.00	+0.00%	-36.17	$3.72M	0.00%
PARDPoniard Pharmaceuticals, Inc.	$0.00	—	0.00	$150	0.00%

About RenovaCare, Inc.

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

RenovaCare, Inc. (RCAR) stock trades at $0.00 with a market capitalization of $8735. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, RenovaCare, Inc. generates a return on equity (ROE) of -568.90%, return on capital employed of -230.49%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.renovacareinc.com